Ambu A/S

Equities

AMBU B

DK0060946788

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 11:26:59 18/07/2024 BST			5-day change	1st Jan Change
133.6 ^DKK	+0.89%		-3.36%	+26.95%

07-11	European shares rise ahead of crucial US inflation data	RE
07-10	Ambu A/S Revises Revenue Guidance for the Fiscal Year 2023/24	CI

Ambu A/S : Download the presentation

January 02, 2022

J.P. MORGAN HEALTHCARE CONFERENCE 2022

SPEAKER

JUAN JOSE GONZALEZ

CEO

SINGLE-USE ENDOSCOPY IS ONE OF THE MOST ATTRACTIVE MEDTECH MARKETS

Drivers creating the single-use endoscopy	Expected single-use
market reinforced during the past year	market in 2025

I	Increased focus on infection control	USD

II Compelling workflow and efficiency benefits

~2.5bn

III Rapid technology advancements	Single-use market
	in 2021

USD

+0.5bn

THE #1 PLAYER IN

SINGLE-USE ENDOSCOPY

Ambu's strategy

Build the most comprehensive and technologically advanced portfolio and ecosystem in single-use endoscopy

by strengthening our R&D modular engine

Leverage a high-scale low-costmanufacturing set-up to enable cost-neutral transition to single-use

Maximize our first-moveradvantage by rapidly scaling our dedicated commercial infrastructure

PERSPECTIVE ON THE COVID-19 PANDEMIC AND RECENT WAVES

•

COVID-19 is driving volatility in the market and putting significant pressure on healthcare systems and MedTech companies

Single-use endoscopy plays an important role to support hospitals efforts to minimize cross contamination and help with the labour shortage by reducing endoscopy workload. As a result, the COVID-19 environment reinforces the value of single-use endoscopy

Our focus continues to be on maximizing our first mover advantage, fulfilling demand for single-use scopes and resuscitators, bringing new products to market and strengthening our infrastructure

Attachments

Original Link
Original Document
Permalink

Disclaimer

Ambu A/S published this content on 03 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 January 2022 08:55:04 UTC.

Latest news about Ambu A/S

European shares rise ahead of crucial US inflation data	07-11	RE
Ambu A/S Revises Revenue Guidance for the Fiscal Year 2023/24	07-10	CI
Ambu A/S(CPSE:AMBU B) dropped from OMX Copenhagen 20 Index	06-20	CI
Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders	05-15	DJ
Transcript : Ambu A/S, Q2 2024 Earnings Call, May 14, 2024	05-14
Ambu A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-14	CI
Nordic Stocks Rose Friday; BioArctic Series B Climbed Highest	04-12	DJ
U.S. Futures Down, European Stocks Mixed	04-11	DJ
Ambu A/S Revises Revenue Guidance for the Fiscal Year 2023/24	04-10	CI
Nordic Stocks Decreased Tuesday; Borr Drilling Took Biggest Hit	01-30	DJ
Transcript : Ambu A/S, Q1 2024 Earnings Call, Jan 30, 2024	01-30
Ambu A/S Reports Earnings Results for the First Quarter Ended December 31, 2023	01-30	CI
Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24	01-30	CI
Ambu A/S Appoints Rummana Hasan as Chief Marketing Officer, Effective February 1, 2024	01-30	CI
Nordic Stocks Moved Upward Friday; Frontline Topped Leaders	01-12	DJ
US Futures Mixed, European Stocks Climb	01-12	DJ
Nordic Shares Rose Wednesday; Hagar Hf. Topped Leaders	12-20	DJ
Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors	12-13	CI
Transcript : Ambu A/S - Shareholder/Analyst Call	12-13
Simon Barnard: A long-term vision at Smithson	12-07
Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors	11-17	CI
Nordic Stocks Moved Upward Wednesday; Vestas Wind Systems Topped Leaders	11-08	DJ
Transcript : Ambu A/S, Q4 2023 Earnings Call, Nov 08, 2023	11-08
Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24	11-08	CI
Ambu A/S Reports Earnings Results for the Full Year Ended September 30, 2023	11-07	CI

Chart Ambu A/S

Duration

Period

More charts

Company Profile

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

30/08/2024 - Q3 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Ambu A/S: An innovative leader in single-use medical equipment

July 02, 2024 at 03:40 pm

More Strategies

Ratings for Ambu A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

132.4 DKK

Average target price

117 DKK

Spread / Average Target

-11.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AMBU A/S	+26.95%	5.17B
ABBOTT LABORATORIES	-4.90%	182B
MEDTRONIC PLC	-1.36%	104B
DEXCOM, INC.	-7.64%	45.58B
HOYA CORPORATION	+9.30%	46.44B
CENCORA, INC.	+9.63%	44.34B
METTLER-TOLEDO INTERNATIONAL, INC.	+13.63%	29.44B
TERUMO CORPORATION	+20.29%	26.8B
WEST PHARMACEUTICAL SERVICES, INC.	-7.12%	23.82B
STERIS PLC	+4.03%	22.61B

Other Medical Equipment, Supplies & Distribution